Technology /AI
First mRNA Treatment for Glycogen Storage Disease Already in Testing Phase
Glycogen storage disease type Ia, also known as von Gierke disease, is a serious inherited disorder with an autosomal recessive inheritance pattern, caused by a deficiency of the enzyme glucose-6-phosphatase. Causal therapy has not been available so far, but this could change in the near future. In a clinical study, the first patient received mRNA therapy aimed at replacing the missing enzyme.
Diagnosis of Skin Malignancies via Mobile Application Successfully Tested in the UK
Skin malignancies are a significant global cause of morbidity and mortality, with melanoma…
Joystick-operated robot intervening in stroke treatment remotely − fiction or promise of the future?
A team of experts from the Massachusetts Institute of Technology (MIT) has developed a telerobotic…
Conferences
News from the world of medicine
All conferences
Popular this week
- A Cap Instead of a Brain Implant?
- Could Artificial Intelligence Help with Emergency Department Triage in the Future?
- AI Can Provide Surgeons with Valuable Data and Real-Time Feedback
- New method for distinguishing tumour tissue could improve glioblastoma resection
- Distribution and Localization of Specifically Modified Exosomes Can Improve the Treatment of Muscular Dystrophies